Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Gene May Be Linked to Emphysema and Lung Cancer

June 14, 2011 10:09 am | News | Comments

A gene linked to emphysema can also be a factor for developing lung cancer, University of Texas, Southwestern Medical Center research indicates.


Genome Interpretation Engine

June 14, 2011 7:26 am | Product Releases | Comments

Knome announced the release of kGAP 2.0, a genome interpretation engine. kGAP 2.0 underlies the genome interpretation and comparison services that Knome provides researchers who seek to make genomic discoveries.


HPLC Column

June 14, 2011 7:21 am | Drug Discovery & Development | Product Releases | Comments

Thermo Fisher Scientific Inc. announced the release of the Accucore HPLC column range, utilizing Core Enhanced Technology to enhance laboratory workflow and efficiency.


ChanTest Working with FDA

June 14, 2011 7:13 am | News | Comments

ChanTest Corporation has entered into a research collaboration with the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research to improve the prediction of cardiac safety.


NIH Finds New Clues into Aging Process

June 14, 2011 6:57 am | News | Comments

A new National Institutes of Health study provides insights about the interaction between a toxic protein called progerin and telomeres, which cap the ends of chromosomes.


Resverlogix Moves Forward on Atherosclerosis Drug

June 14, 2011 6:53 am | News | Comments

Resverlogix Corp. announced that chronic repeated-dose toxicology studies on its lead compound, RVX-208, support the initiation of its longer duration, Phase 2b, clinical trial ASSURE.


FDA Releases Nanotech Guidance

June 14, 2011 6:49 am | News | Comments

The U.S. Food and Drug Administration released draft guidance to provide regulated industries with greater certainty about the use of nanotechnology, which generally involves materials made up of particles that are one billionth of a meter in size.


Blocking Enzyme Controls Imflammation, Cancer

June 14, 2011 6:46 am | News | Comments

There is an intimate and complex relationship between inflammation and cancer; and it is well established that tumors secrete many different chemicals that attract host cells which drive inflammation and help to support tumor growth.


Ranibizumab May Help Prevent Blindness

June 14, 2011 6:42 am | News | Comments

A study suggests that administering the drug ranibizumab is associated with reducing the magnitude of legal blindness and visual impairment caused by age-related macular degeneration.


New Labels to Reduce Potentially Deadly Errors

June 14, 2011 6:31 am | by Linda A. Johnson | News | Comments

Drugmaker Merck & Co. soon will be shipping many of its top medications to pharmacies in containers with labels redesigned to prevent dispensing errors.


UT Southwestern Wins ‘International Project of the Year’ Award

June 13, 2011 12:25 pm | News | Comments

The discovery of a potential new anti-malarial drug by a University of Texas, Southwestern Medical Center-led research team has been awarded Project of the Year by Medicines for Malaria Venture (MMV).


Ranibizumab May Reduce Blindness from Macular Degeneration

June 13, 2011 12:11 pm | News | Comments

A study suggests the drug ranibizumab is associated with reducing the magnitude of legal blindness and visual impairment caused by age-related macular degeneration.


Cediranib Benefits Patients with Rare Type of Cancer

June 13, 2011 12:04 pm | News | Comments

An experimental drug, cediranib, may benefit patients with a rare, slow-growing cancer called alveolar soft part sarcoma (ASPS), according to results from a clinical trial.


Living Laser Device Basis of GFP-Expressing Cell

June 13, 2011 11:58 am | News | Comments

Two investigators at the Wellman Center for Photomedicine at Massachusetts General Hospital have developed a living laser in which a single cell genetically engineered to express green fluorescent protein (GFP) can be used to amplify the light particles called photons into nanosecond-long pulses of laser light.


Computer Tool Helps Finds Genetic Mistakes that Fuel Cancer

June 13, 2011 11:52 am | News | Comments

A computer tool for finding the genetic missteps that fuel cancer has been developed by St. Jude Children's Research Hospital and Washington University Pediatric Cancer genome project investigators.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.